MRNA$221.720.47%-1.04
After Hours: 221.50-0.22 -0.10%
Moderna Inc (MRNA)
Date: 2026-10-30 16:00O: 220.53H: 227.81L: 217.22C: 221.72Vol: 8.582M
Moderna Inc stock is traded at $221.72, with a volume of 8,582,012. It is down -0.47% in the last 24 hours and up +15.14% over the past month. Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Previous Close:
$222.76
Open:
$220.53
24h Volume:
8,582,012
Relative Volume:
0.45
Market Cap:
$88.52B
Revenue:
$2.23B
Net Income/Loss:
-$3.19B
P/E Ratio:
-
EPS:
-$8.15
Net Cash Flow:
-$1.60B
1W Performance:
+10.80%
1M Performance:
+15.14%
6M Performance:
+382.63%
1Y Performance:
+687.92%
1-Day Range:
$217.22$227.81
1-Week Range:
$179.53$227.81
52-Week Range:
$22.28$254.48
Moderna Inc Stock (MRNA) Company Profile
Name
Moderna IncSector
HealthcareIndustry
BiotechnologyPhone
(617) 714-6500Address
325 BINNEY STREET, CAMBRIDGE, USACompare MRNA vs VRTX, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Moderna Inc Stock (MRNA) Upgrades & Downgrades
Moderna Inc Stock (MRNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Moderna Inc Stock (MRNA) Insider Trading
- Hoge StephenOct 15 '26President
- Transaction
- Option Exercise
- Cost
- $12.21
- #Shares
- 76,452
- Value ($)
- 933,479
- #Shares Total
- 1,675,710
- Hoge StephenOct 15 '26Officer
- Transaction
- Proposed Sale
- Cost
- $220.72
- #Shares
- 39,145
- Value ($)
- 8,640,033
- #Shares Total
- 0
- Hoge StephenOct 15 '26President
- Transaction
- Sale
- Cost
- $220.72
- #Shares
- 39,145
- Value ($)
- 8,640,084
- #Shares Total
- 1,636,565
- Hoge StephenOct 14 '26Officer
- Transaction
- Proposed Sale
- Cost
- $213.48
- #Shares
- 39,224
- Value ($)
- 8,373,519
- #Shares Total
- 0
- Hoge StephenOct 14 '26President
- Transaction
- Sale
- Cost
- $213.48
- #Shares
- 39,224
- Value ($)
- 8,373,453
- #Shares Total
- 1,599,258
- Hoge StephenSep 15 '26President
- Transaction
- Option Exercise
- Cost
- $12.21
- #Shares
- 76,452
- Value ($)
- 933,479
- #Shares Total
- 1,602,310
- Hoge StephenSep 15 '26President
- Transaction
- Sale
- Cost
- $146.07
- #Shares
- 40,281
- Value ($)
- 5,883,846
- #Shares Total
- 1,562,029
- Hoge StephenSep 15 '26Officer
- Transaction
- Proposed Sale
- Cost
- $146.07
- #Shares
- 40,281
- Value ($)
- 5,883,709
- #Shares Total
- 0
- Hoge StephenSep 14 '26President
- Transaction
- Option Exercise
- Cost
- $12.21
- #Shares
- 76,453
- Value ($)
- 933,491
- #Shares Total
- 1,566,152
- Hoge StephenSep 14 '26Officer
- Transaction
- Proposed Sale
- Cost
- $144.13
- #Shares
- 40,294
- Value ($)
- 5,807,746
- #Shares Total
- 0
